Long non-coding RNAs offer new pathways to overcome cancer treatment resistance

by rss feed | Oct 12, 2026 | News Feeds

Scientists are highlighting long non-coding RNAs (lncRNAs) as promising targets in the effort to overcome one of cancer treatment's most persistent challenges: therapeutic resistance. Read Original...

RNA modification enzyme FTO shows therapeutic promise in gastrointestinal cancers

by rss feed | Oct 12, 2026 | News Feeds

A new review in Genes & Diseases highlights FTO, an enzyme involved in RNA modification, as a potentially important biomarker and therapeutic target across gastrointestinal cancers. Read Original...

Review highlights EP4 receptor as target for inflammatory diseases

by rss feed | Oct 12, 2026 | News Feeds

A review published in Genes & Diseases highlights the prostaglandin E2 receptor subtype 4 (EP4) as an important regulator of inflammation and a promising therapeutic target for a wide range of inflammatory and inflammation-related diseases. Read Original...

Targeting mitochondrial vulnerabilities could help treat triple-negative breast cancer

by rss feed | Oct 12, 2026 | News Feeds

A deeper understanding of mitochondrial function could create new opportunities for treating triple-negative breast cancer (TNBC), one of the most aggressive and difficult-to-treat forms of breast cancer. Read Original...

Targeting lipophagy could help treat metabolic and oxidative stress-related diseases

by rss feed | Oct 12, 2026 | News Feeds

A review published in Genes & Diseases highlights lipophagy, the cellular process that selectively breaks down lipid droplets, as a potentially important therapeutic target for conditions driven by disrupted lipid metabolism and oxidative stress. Read Original...